Beyond Weight Loss: How Semaglutide is Changing the Game for Addiction
- The Modern Domestic Woman
- 2 hours ago
- 2 min read
GLP-1 medications have been making waves for helping with weight loss and blood sugar, but now they’re also catching some attention for something super interesting, such as how they might help calm those tough cravings, especially for alcohol, and maybe even things like gambling and shopping urges. If you’ve ever felt like your cravings just won’t quit, this could be a game-changer.
GLP-1s and Alcohol Cravings: What’s the Buzz?
Simply put, GLP-1 is a hormone that talks to your brain about when you’re full, but it also chats with the parts of your brain that control reward and motivation—the areas that light up when you want that glass of wine or that shopping spree. When GLP-1 meds are working, they help balance those signals, so those cravings don’t feel so overwhelming. Brain scans show that these meds can calm down the “reward” centers, making alcohol or other urges less tempting.
What About Gambling and Shopping?
Here’s where it gets really interesting, but a bit more mysterious. While the strongest proof is for alcohol, early research hints that GLP-1 meds might also help with other urges like gambling or compulsive shopping. Some small studies and animal research suggest these meds could help reduce impulsive behaviors, but scientists are still gathering the full picture. So, it’s a promising area to watch.
GLP-1 meds aren’t officially approved to treat alcohol cravings or compulsive behaviors yet, but the research is growing fast. If you’re already using these meds for weight or blood sugar, it’s pretty cool to know they might also help quiet those nagging urges. Just remember, they’re not a magic fix for addiction, but they could be a helpful part of the puzzle.
Sources:
Hendershot, C. S., et al. (2025). Once-weekly semaglutide in adults with alcohol use disorder: A randomized clinical trial. JAMA Psychiatry, 82(4), 395–405. https://doi.org/10.1001/jamapsychiatry.2024.4789 Eshraghi, Reza et al. “Effects of glucagon-like peptide-1 receptor agonists on alcohol consumption: a systematic review and meta-analysis.” EClinicalMedicine vol. 90 103645. 14 Nov. 2025, doi:10.1016/j.eclinm.2025.103645 Petrie, Gavin N, and Leah M Mayo. “GLP-1 receptor agonists for the treatment of alcohol use disorder.” The Journal of clinical investigation vol. 135,9 e192414. 1 May. 2025, doi:10.1172/JCI192414 Lähteenvuo, Markku et al. “Repurposing Semaglutide and Liraglutide for Alcohol Use Disorder.” JAMA psychiatry vol. 82,1 (2025): 94-98. doi:10.1001/jamapsychiatry.2024.3599